Attached files
file |
filename |
EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORP | amexdrug10kexh322.txt |
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORP | amexdrug10kexh312.txt |
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - AMEXDRUG CORP | amexdrug10kexh321.txt |
EX-10.19 - LEASE AGREEMENT BETWEEN FULLERTON BUSINESS CENTER, LLC, LESSOR, AND ALLIED MED, INC., LESSEE, DATED NOVEMBER 9, 2009 - AMEXDRUG CORP | amrx10k20091231ex10-19.htm |
EX-10.20 - THIRD AMENDMENT TO LEASE AGREEMENT BETWEEN FULLERTON BUSINESS CENTER, LESSOR, AND ALLIED MED, INC., LESSEE, DATED NOVEMBER 5, 2008 - AMEXDRUG CORP | amrx10k20091231ex10-20.htm |
10-K - AMEXDRUG CORPORATION FORM 10-K DECEMBER 31, 2009 - AMEXDRUG CORP | amexdrug10k.txt |
================================================================================
EXHIBIT 31.1
SECTION 302
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
I, Jack Amin, chief executive officer of Amexdrug Corporation (the
"registrant"), certify that:
1. I have reviewed this annual report on Form 10-K of Amexdrug
Corporation;
2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:
(a) designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under
our supervision, to ensure that material information relating
to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly
during the period in which this report is being prepared;
(b) designed such internal control over financial reporting, or
caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes
in accordance with generally accepted accounting principles;
(c) evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this
report based on such evaluation; and
(d) disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during
the registrant's most recent fiscal quarter (the registrant's
fourth fiscal quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial
reporting; and
5. The registrant's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):
(a) all significant deficiencies and material weaknesses in the
design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the
registrant's ability to record, process, summarize and report
financial information; and
(b) any fraud, whether or not material, that involves management
or other employees who have a significant role in the
registrant's internal control over financial reporting.
Date: March 30, 2010 By /s/ Jack Amin_
----------------------------------
Jack Amin, Chief Executive Officer
-------------------------------------------------------------------------------